Allergic rhinitis and bronchial asthma in preschool children: possibilities of modern therapy for comorbid diseases

The article presents modern views on the problem of bronchial asthma and allergic rhinitis as a comorbidity in children. The concept of single chronic allergic respiratory syndrome is considered. Following international and national recommendations for the management of patients with bronchial asthma and allergic rhinitis, the impact of leukotriene receptor antagonists in the treatment of this comorbidity is determined. The compliance in the treatment of children with bronchial asthma and ways of its optimization are given. The use of montelukast sodium in the treatment of the persistent forms of allergic rhinitis and bronchial asthma in children is scientifically substantiated. The treatment outcomes for the control therapy of mild persistent forms of bronchial asthma and allergic rhinitis in children aged 2–6 years with such leukotriene receptor antagonists as montelukast sodium are shown.

1. Dehghani R, Kassiri H, RezvanTalaee MS, Mesgari L, Chimehi E, Dehghani A. Studying Women’s Allergy Rate to Cosmetics in Kashan, Central Iran. Entomol. appl. sci. lett. 2018;6(1):45-50.
2. Graziano R., Ilio C.D., Conti P. [et al.] Advances in Therapy with Antileukotriene Drugs. Annals of Clinical and Laboratory Science. 2004;34:379-387.
3. Zabololotny D.I., Lykov A.A., Okhotnikova A.N., Kosakovsky A.L. [et al]. Allergic rhinitis in children (monograph). Kiev: Logos, 2016.
4. Antipkin Yu.G., Umnica T.R., Lapshin V.F. [et al] Bronchial asthma combined with allergic rhinitis in children the role of antihistamines in treatment. Asthma and allergy. 2014;4:60-65.
5. Gurtovaya M.N., Grebneva N.N., Prokopyev N.Y. Allergic rhinitis and bronchial asthma: incidence, causes, clinic, and treatment. Young scientist. 2014;2:318-326.
6. Malik M, Khan A, Hussain A, Hashmi A. Prevalence of Depression among Asthmatic Patients in Pakistan: Challenges for Integrated Team Care. Int. J. Pharm. Res. Allied Sci. 2017 Jan 1;6(4):8-1
7. Ovcharenko S.I., Opalenova V.A. Allergic rhinitis, and bronchial asthma: Lordestin effectiveness assessment. Pharmateka. 2012;15. Pharmateca.ru/ru/archive/article/8594 [Online]. Available: [Accessed: 29 Feb, 2020].
8. Mohebbi A, Aghajanpour M. From Allergic Rhinitis to Spontaneous Cerebrospinal Fluid Leak: A rare Case Report of Sphenoid Sinus Defect. J. Biochem. Technol. 2018;9(1):70-3.
9. Namazova-Baranova L.C. Allergy in children - from theory to practice. Moscow, 2010.
10. Gentile D., Bartholow A., Valovirta E. [et al.] Current and Future Directions in Pediatric Allergic Rhinitis. J. Allergy Clin. Immunol: In Practice. 2011;1(3):214-226.
11. Brozek J.L., Bousquet J., Baena-Cagnani C.E. [et al.]. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 Revision. J. Allergy Clin. Immunol. 2010;126:466-476.
12. Chawes Bо L. K. Upper and lower airway pathology in young children with allergic and nonallergic rhinitis. Dan. Med. Bull. 2011;58 (5):B4278
13. Bousquet J., Khaltaev N., Cruz A.A. [et al.] Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GALEN, and AllerGen. Allergy. 2008;63(86):8-160.
14. Canonica G.W., Сompalati Е. Minimal persistent inflammation in allergic rhinitis: Implications for current treatment strategies. Clin. Exper. Immunol. 2009;158:260-271.
15. Boulet L. Ph., Boulay M. Asthmarelated comorbidities. Expert Rev. Respir. Med. 2011;5(3):377-393.
16. Takemura М., Niimi А., Matsumoto Н. [et al.] Clinical, Physiological and Anti-Inflammatory Effect of Montelukast in Patients with Cough Variant Asthma. Respiration. 2012;83(4):308-315
17. Abdallah A.M. Low dose inhaled steroid compared to leukotriene antagonist in children with mild persistent asthma. EAACI 2014, European Academy of Allergy and Clinical Immunology Congress, Copenhagen, Denmark, Jun 7-11, 2014. Abstr. 748.
18. Vasilevsky I.V., Skeptian E. The use of SINGULAR is a new strategy for allergic rhinitis treatment. ARS medica. 2011;3:159-172.
19. Geppe N.A., Ozerskaya I.V. The role of cromones in bronchial asthma and allergic rhinitis treatment in children. Pulmonology and allergology. 2009;1:11-14.
20. Burgess S., Sly P., Devadason S. Аdherence with preventive medication in childhood asthma. Pulmonary Medicine. 2011.
21. Nenasheva N.M. Present and future of leukotriene receptor antagonists in the bronchial asthma and allergic disease therapy. Effective pharmacotherapy. Pulmonology and otorhinolaryngology. 2012;4:22-46.
22. Okhotnikova A.N., Gladush Yu.I., Bondarenko L.V. [et al]. Allergic rhinitis in children. Urgent issues of diagnosis and treatment. Clinical immunology. Allergology. Infectology. 2015;1(80):26-36.
23. Ciolkowskа J., Mazurek H., Stasiowska B. Evaluation of stepdown therapy from an inhaled steroid to montelukast in childhood asthma. Allergol. Immunopathol. 2014;42(4):342-347.
24. Nedelskaya S.M., Yartseva D.A., Mazur V.I. [et al] Allergic rhinitis and bronchial asthma pollen etiology in children. Retrospective clinical course study. Modern pediatrics. 2013;1 (49):24-30.
25. Romanyuk L.I. Allergic rhinitis as a comorbide condition of bronchial asthma. Asthma and allergy. 2013;2:62-65.
26. Bulgakova V.A. Modification of bronchial asthma therapy. Possibilities to improve virus-induced asthma treatment efficiency in children. Pharmateka. 2015;4:6-12.
27. Umanets T.R. Bronchial asthma and allergic rhinitis: ways to optimize compliance and treatment efficiency. Asthma is allergy. 2015;1:61-64.
28. Artyuch A. Leukotriene receptor antagonists in bronchial asthma therapy. Time-proven efficiency. Clinical immunology. Allergology. Infectology. 2017;1(98):40-42.